Lyell Immunopharma, Inc. · NASDAQ:LYEL

Innovative Cellular Therapeutics Holdings Ltd sold 10 Lyell Immunopharma, Inc. shares (Form 4)

Traded Jul 17, 2026 · Filed Jul 20, 2026

On Jul 17, 2026, Innovative Cellular Therapeutics Holdings Ltd (10% owner) sold 10 Lyell Immunopharma, Inc. shares at US$13.70 for US$137 under a trading plan, leaving 2,857,480 shares. Filed Jul 20, 2026 (Form 4).

Sold: 10 shares
Price: US$13.70
Value: US$137
Holding after: 2,857,480 shares
Trading plan: Yes (Made under a plan set in advance)
Role: 10% owner

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Jul 17, 2026	Common Stock	Sale	10	US$13.70	2,857,480	Direct

Source

View original at SEC

Related